SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001358403-19-000050
Filing Date
2019-04-26
Accepted
2019-04-26 16:08:56
Documents
2
Period of Report
2019-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_155630932175313.html 3  
1 FORM 3 wf-form3_155630932175313.xml 3 6198
2 POWER OF ATTORNEY poa-paulwoodard.htm EX-24 3318
  Complete submission text file 0001358403-19-000050.txt   11036
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Woodard Jr Joseph Paul (Reporting) CIK: 0001773944 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 19771838